## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no full text, figures, tables, or supplementary materials were provided
- **Shared manuscript claim summary** The authors propose that phosphorylation of ABLIM1 in intrinsically disordered regions, at sites altered in a canine heart failure model with reduced GSK3β activity, changes the conformational ensemble of these regions, which in turn modulates LIM domain interactions with titin. They further claim that this altered interaction reduces myosin head recruitment for cross-bridge formation, providing a mechanistic explanation for diminished length-dependent activation observed previously.
- **Visible evidence base** Abstract text only; no methodological details, simulation parameters, validation data, or quantitative results are available
- **Missing materials affecting confidence** Full manuscript, all figures and tables, simulation protocols, force field parameters, system preparation details, validation of the contraction model, and any statistical analyses

## Reviewer
- **Overall assessment** The abstract presents an interesting and potentially significant hypothesis linking phosphorylation-driven conformational changes in an intrinsically disordered region of ABLIM1 to altered titin binding and downstream contractile dysfunction. The multiscale approach, combining molecular dynamics with a state-based contraction model, is ambitious and relevant. However, the abstract alone provides insufficient evidence to evaluate the technical soundness of the simulations, the robustness of the conformational ensemble predictions, or the validity of the physiological extrapolation. The central mechanistic chain is plausible but not established from the supplied material.
- **Who would be interested in the results, and why** Researchers in cardiac muscle physiology, myofilament protein regulation, intrinsically disordered protein biology, and computational biophysics would find these results relevant. The work bridges molecular-level conformational dynamics with whole-sarcomere mechanical behavior, which could interest those studying heart failure mechanisms and seeking new therapeutic targets in the sarcomere.
- **Major strengths** The hypothesis is clearly framed and mechanistically motivated. The multiscale approach is appropriate for the question posed. The reframing of IDRs as functional tunable elements rather than structural noise is conceptually valuable. The connection to a disease-relevant model (heart failure with reduced GSK3β activity) enhances translational relevance.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3
- **Assessment against Nature-style criteria**  
  - Originality: The hypothesis that phosphorylation in IDRs of ABLIM1 modulates titin binding and contractile function is novel and not previously reported in the supplied material.  
  - Scientific importance: If established, the findings would provide a new molecular mechanism for length-dependent activation deficits in heart failure, which is clinically relevant.  
  - Interdisciplinary readership: The work spans computational biophysics, protein biochemistry, and cardiac physiology, which could attract a broad audience.  
  - Technical soundness: Cannot be assessed from the abstract alone. No simulation details, convergence criteria, force field choices, or model validation are provided.  
  - Readability for nonspecialists: The abstract is well written and accessible, with clear logical flow from hypothesis to conclusion.
- **Recommendation posture** Currently not established from the provided evidence. Supportive if technical concerns are resolved in the full manuscript.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Technical soundness  
- **Claim pointer** The authors claim that phosphorylation at sites known to be altered in a canine heart failure model with reduced GSK3β activity changes the conformational ensemble of ABLIM1 IDRs.  
- **Evidence pointer** Abstract only; location not provided  
- **Concern** The abstract provides no details on the molecular dynamics simulation setup, including force field parameters, water model, ionic conditions, simulation length, replica exchange or enhanced sampling methods, or convergence criteria. Without these, the reliability of the predicted conformational ensembles cannot be evaluated.  
- **Why it matters** Conformational ensemble predictions from MD simulations are highly sensitive to force field choice and sampling adequacy. If the ensembles are not converged or the force field is inappropriate for IDRs, the central claim of phosphorylation-induced conformational change is unsupported.  
- **Resolution test** Provide full simulation methods, including force field validation for IDRs, convergence metrics, and comparison of simulated ensembles to any available experimental data (e.g., SAXS, FRET, or NMR).

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Evidence strength  
- **Claim pointer** The authors claim that the ensemble change influences the ability of ABLIM1 LIM domains to interact with titin.  
- **Evidence pointer** Abstract only; location not provided  
- **Concern** The abstract states that phosphorylation affects LIM domain/titin interactions but provides no quantitative data, such as binding free energies, dissociation constants, or changes in contact probabilities. The direction and magnitude of the effect are not specified.  
- **Why it matters** The mechanistic chain depends on a clear demonstration that phosphorylation alters the binding affinity or kinetics of the LIM domain/titin interaction. Without quantitative evidence, the claim remains speculative.  
- **Resolution test** Provide binding free energy calculations, enhanced sampling of the binding interface, or experimental binding assays (e.g., ITC, SPR, or pull-downs) comparing phosphorylated and unphosphorylated states.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Model validity  
- **Claim pointer** The authors claim that reduced myosin head recruitment for cross-bridge formation, resulting from modified LIM domain/titin interactions, provides a mechanism for diminished length-dependent activation.  
- **Evidence pointer** Abstract only; location not provided  
- **Concern** The state-based contraction model is described only in passing. No details are given on model parameters, how the molecular-scale predictions were translated into model inputs, or how the model output was validated against experimental data on length-dependent activation.  
- **Why it matters** The physiological conclusion rests entirely on the contraction model. If the model is not calibrated or validated, the extrapolation from molecular dynamics to whole-sarcomere behavior is unjustified.  
- **Resolution test** Provide full model equations, parameter values, sensitivity analysis, and validation against experimental force-length or force-pCa relationships in control and heart failure conditions.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Abstract statement on GSK3β activity  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The abstract mentions "sites known to be altered in a canine model of heart failure with reduced GSK3β activity" but does not specify which sites or how GSK3β activity is linked to phosphorylation at those sites.  
- **Required correction** Specify the phosphorylation sites and provide a brief statement on the established link between GSK3β activity and ABLIM1 phosphorylation.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Completeness  
- **Affected element** Abstract description of multiscale approach  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The abstract states "a multiscale modeling approach including molecular dynamics simulations" but does not describe the other scales or how they are integrated.  
- **Required correction** Briefly describe the components of the multiscale approach and how they are connected.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Interpretation  
- **Affected element** Abstract conclusion on IDR function  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The conclusion that IDRs are "key, tunable elements" is presented as a general insight, but the evidence is limited to one protein and one modification type.  
- **Required correction** Soften the generalization or provide additional context on how this finding may extend to other IDR-containing myofilament proteins.

## Risk / unsupported claims
- The claim that phosphorylation at specific sites changes the conformational ensemble of ABLIM1 IDRs is unsupported without simulation details and convergence evidence.
- The claim that ensemble changes influence LIM domain/titin interactions is unsupported without quantitative binding data.
- The claim that reduced myosin head recruitment explains diminished length-dependent activation is unsupported without model validation.
- The general statement that IDRs are "key, tunable elements" controlling protein interactions and mechanical behavior in the sarcomere is an extrapolation beyond the specific system studied.